Dennis Deapen

TL;DR: No exonic variants or gene-based analyses were statistically significantly associated with breast cancer overall or by ER-, PR-, or HER2-defined subtype, and the exome chip may not be associated with overall breast cancer or subtype susceptibility.

TL;DR: Primary treatment is not associated with 2-year general HRQOL outcomes in prostate cancer, and men who are more bothered by their urination or impotence are more likely to report worse quality of life, which implies that future research should be directed toward finding ways to improve treatmentrelated outcomes or help patients better cope with their posttreatment urinary or sexual dysfunction.

TL;DR: Light is shed on the relative roles of age, race/ethnicity, sex, and socioeconomic status in metastatic disease presentation in AYAs and the connection between sociodemographic risk factors and biological drivers of metastases to help facilitate risk reduction and earlier detection of these deadly diseases.

TL;DR: AYAs diagnosed with these metastatic cancers have better survival than OAs, but outcomes remain dismal, and Sociodemographic disparities affecting AYAs within kidney, uterine, ovarian, and colorectal cancer could indicate plausible effects of biology, environment, and/or access.